News last update:7 Aug 2012

US enzymes demand to increase 5.1% annually

Demand for enzymes in the US is forecast to rise more than 5% annually to $2.7 billion in 2014. Solid industry growth in recent years has been founded upon advances in higher-value, specialty enzymes used in applications such as pharmaceuticals, research and biotechnology, and biocatalysts, as well as the emerging biofuels market.

Going forward, gains will come from continued expansion in these areas as enzyme producers create new niches in the treatment of lysosomal storage disorders (LSDs), the use of biocatalysts in pharmaceutical and fine chemical manufacturing, and in new cellulase formulations enabling biomass-based ethanol refining to reach an economically feasible industrial scale.
Dynamic growth in pharmaceutical market
Over the past decade, pharmaceuticals surpassed the former mainstay of the enzyme market, food and beverage processing, to become the highest value source of enzyme demand.
The nearly double-digit growth in pharmaceutical enzymes seen from 1999 to 2009 was driven by several key enzyme medications holding orphan drug status for treating rare LSDs.
Biofuels market shift toward cellulase enzymes
Demand for enzymes used in making biofuels has grown strongly as the industry has rapidly scaled up its production capacity and invested in new technology to meet US government quotas.
To date, enzyme growth in the biofuels market has come largely from alpha amylases and glucoamylases used in conventional starch-based ethanol processing.
Gains in the future will be derived from a shift in the product mix toward cellulases and related enzymes needed to refine biomass (cellulosic) ethanol, which is mandated to reach production of 8.5 billion gallons in 2019.
Stable growth for industrial enzymes
Although specialty enzymes are becoming the higher-value segment, industrial enzymes will continue to see stable growth in markets such as pulp and paper processing, animal feed, cosmetics and toiletries, and cleaning products.
Market leaders such as Novozymes and Danisco, competing in the industrial segment, will continue to fight off the downward sales pressures coming from commoditization and maturing markets by introducing new, more technical and specially tailored enzymes.
The animal feed enzyme market will see moderating benefits from the widespread adoption of phytases as this application matures.
In all industrial markets, demand for enzymes will be supported by their more environmentally friendly nature on a variety of levels, including their ability to substitute for harsh chemical solvents.
Study coverage
This new industry study presents historical demand data (1999, 2004 and 2009) plus forecasts for 2014 and 2019 by market and product. The study also considers market environment factors, evaluates company market share and profiles 34 industry competitors.
The study can be purchased from ReportLinker.com following this link: US enzymes market

Dick Ziggers

Or register to be able to comment.